Carboplatin-induced thrombocytopenia in ovarian cancer: A focus on predictive factors

被引:0
|
作者
Mazzeo, R. [1 ]
Bartoletti, M. [1 ]
de Scordilli, M. [1 ]
Alberti, M. [1 ]
Michelotti, A. [1 ]
Lisanti, C. [1 ]
Parnofiello, A. [1 ]
Bertoli, E. [1 ]
Buriolla, S. [1 ]
Pelizzari, G. [1 ]
Cortiula, F. [1 ]
Basile, D. [1 ]
Gagno, S. [2 ]
Scalone, S. [1 ]
Nicoloso, M. S. [3 ]
Corsetti, S. [1 ]
Lombardi, D. [1 ]
Gerratana, L. [1 ]
Sorio, R. [1 ]
Puglisi, F. [1 ]
机构
[1] Ctr Riferimento Oncol CRO, Dept Med Oncol, Unit Med Oncol & Canc Prevent, Aviano, Italy
[2] Ctr Riferimento Oncol CRO, Clin & Expt Pharmacol Unit, Aviano, Italy
[3] Ctr Riferimento Oncol CRO, Unit Mol Oncol, Aviano, Italy
关键词
D O I
10.1016/j.annonc.2020.08.981
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
842P
引用
收藏
页码:S631 / S631
页数:1
相关论文
共 50 条
  • [21] An ex vivo chemoresponse assay predicts carboplatin-induced progression-free interval in ovarian cancer.
    Coleman, R
    Herzog, T
    Hosford, S
    Sevin, BU
    Wells, A
    Fiori, L
    Gallion, H
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 482S - 482S
  • [22] Effects of interleukin-11 on carboplatin-induced thrombocytopenia in rats and in combination with stem cell factor
    Yonemura, Y
    Kawakita, M
    Miyake, H
    Miyazoe, T
    Fujimoto, K
    Takatsuki, K
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 1997, 65 (04) : 397 - 404
  • [23] RELATIONSHIP BETWEEN CARBOPLATIN-INDUCED THROMBOCYTOPENIA AND VARIOUS GLOMERULAR FILTRATION RATE-SIMULATED FORMULAS
    Kawazoe, Hitoshi
    Ohnishi, Kanako
    Motoki, Yuuki
    Hidaka, Noriaki
    Ido, Keiko
    Suemaru, Katsuya
    Araki, Hiroaki
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 44 - 45
  • [24] Carboplatin and paclitaxel interact antagonistically in a megakaryoblast cell line - a potential mechanism for paclitaxel-mediated sparing of carboplatin-induced thrombocytopenia
    Guminski, AD
    Harnett, PR
    deFazio, A
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2001, 48 (03) : 229 - 234
  • [25] Carboplatin and paclitaxel interact antagonistically in a megakaryoblast cell line – a potential mechanism for paclitaxel-mediated sparing of carboplatin-induced thrombocytopenia
    Alexander D. Guminski
    Paul R. Harnett
    Anna deFazio
    [J]. Cancer Chemotherapy and Pharmacology, 2001, 48 : 229 - 234
  • [26] Notch3 induces epithelial-mesenchymal transition and attenuates carboplatin-induced apoptosis in ovarian cancer cells
    Gupta, Nidhi
    Xu, Zhihua
    El-Sehemy, Ahmed
    Steed, Helen
    Fu, YangXin
    [J]. GYNECOLOGIC ONCOLOGY, 2013, 130 (01) : 200 - 206
  • [27] Carboplatin-induced early cochlear lesion in chinchillas
    Wang, J
    Ding, DL
    Salvi, RJ
    [J]. HEARING RESEARCH, 2003, 181 (1-2) : 65 - 72
  • [28] Dose response of carboplatin-induced nephrotoxicity in rats
    Husain, K
    Jagannathan, R
    Hasan, Z
    Trammell, GL
    Rybak, LP
    Hazelrigg, S
    Somani, SM
    [J]. PHARMACOLOGY & TOXICOLOGY, 2002, 91 (02): : 83 - 89
  • [29] Identifying predictive biomarkers of carboplatin resistance in ovarian cancer
    Penzvalto, Z.
    Lanczky, A.
    Gyorffy, B.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S737 - S738
  • [30] Time response of carboplatin-induced nephrotoxicity in rats
    Husain, K
    Whitworth, C
    Rybak, LP
    [J]. PHARMACOLOGICAL RESEARCH, 2004, 50 (03) : 291 - 300